Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $17.41 USD
Change Today +0.92 / 5.58%
Volume 91.2K
MRNS On Other Exchanges
Symbol
Exchange
NASDAQ GM
Stuttgart
As of 8:10 PM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Christopher Michael Cashman

Executive Chairman, Chief Executive Officer and President, Marinus Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 61 board members in 7 different organizations across 5 different industries.

See Board Relationships
58$2,028,000
As of Fiscal Year 2014

Background*

Mr. Christopher Michael Cashman, also known as Chris, has been Executive Chairman of Marinus Pharmaceuticals, Inc. since September 2011 and has been its Chief Executive Officer and President since October 2012. Mr. Cashman co-founded Protez Pharmaceuticals, Inc. in 2003 and served as its Chief Executive Officer and President. He has over 30 years of experience in pharmaceutical business operations and commercial development. Mr. Cashman served as the Chief Executive ...

Read Full Background

Corporate Headquarters*

100 Matsonford Road
Radnor, Pennsylvania 19087

United States

Phone: 484-801-4670
Fax: --

Board Members Memberships*

Director
Director
Director
2010-Present
Director
2010-Present
Director
2011-Present
Executive Chairman, Chief Executive Officer and President
2015-Present
Director

Education*

BS
University of Minnesota
MS
Purdue University

Other Affiliations*

Annual Compensation*

Salary$325,000
Bonus$130,000
Total Annual Compensation$455,000

Stock Options*

Exercisable Options176,895
Unexercisable Options341,289
Total Number of Options518,184

Total Compensation*

Total Annual Cash Compensation$455,000
Total Short Term Compensation$455,000
Total Calculated Compensation$2,028,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRNS:US $17.41 USD +0.92

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Joseph Jimenez Jr., MBAChief Executive Officer
Novartis AG
SFr.6.1M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MARINUS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.